Abstract:Background: Organoids, which enable disease modeling and drug screening closer to an in vivo environment, can be isolated and grown from organs such as the brain, small intestine, kidney, lungs, and liver. To facilitate the establishment of liver and small intestinal organoids, we developed efficient protocols for cholangiocytes and intestine crypts collecting and organoid culturing. Methods: Cholangiocytes were collected from intrahepatic bile ducts, the gallbladder, and small intestine crypts by gravity settling and multistep centrifugation methods. The cells isolated were embedded with Matrigel and grew in three-dimensional spheroids in a suitable culture medium. The stability of organoid cells was assessed by subculture, cryopreservation, and thawing. RNA and DNA extraction of organoids, as well as immunostaining procedure, were also optimized. Hand-picking procedures were developed and performed to ensure similar growth characteristics of organoids. Results: A large number of cholangiocytes and small intestine crypts were collected under these protocols. Cholangiocytes developed into cyst-like structures after 3–4 days in Matrigel. After 1–2 weeks of cultivation, small intestinal organoids (in-orgs) developed buds and formed a mature structure. Compared to organoids derived from the gallbladder, cholangiocyte organoids (Cho-orgs) from intrahepatic the bile ducts grew more slowly but had a longer culture term, expressed the cholangiocytes markers Krt19 and Krt7, and recapitulated in vivo tissue organization. Conclusions: Our protocols simplified the cell collection procedure and avoided the possibility of exposing tissue-derived stem cells to mechanical damage or chemical injury by gravity settling and multistep centrifugation. In addition, our approach allowed similar growth characteristics of organoids from different mammalian tissue sources. The protocol requires 2–4 weeks to establish a stable organoid growth system. Organoids could be stably passaged, cryopreserved, and recovered under protocol guidance. Besides, the organoids of cholangiocytes and small intestines retained their original tissue characteristics, such as tissue-specific marker expression, which prepares them for further experiments such as preclinical in vitro trials and mechanism research studies.

Establishment and identification of human gallbladder organoid culture system

Cell Isolation and Organoid Culture from Mouse Liver and Small Intestine

Highly Efficient Methods to Culture Mouse Cholangiocytes and Small Intestine Organoids

Organoids: Construction and Application in Gastric Cancer

Bioengineered Tubular Biliary Organoids

Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet?

Biliary epithelial cell differentiation of bipotent human liver-derived organoids by 2D and 3D culture

A Novel 3d Liver Organoid System for Elucidation of Hepatic Glucose Metabolism

Use of human tissue stem cell-derived organoid cultures to model enterohepatic circulation

Liver and bile duct organoids and tumoroids

Liver Organoid Culture Methods

3D organoid cultivation improves the maturation and functional differentiation of cholangiocytes from human pluripotent stem cells

Characteristics of a Novel Cell Line ZJU-0430 Established from Human Gallbladder Carcinoma

Regional Differences in Human Biliary Tissues and Corresponding In Vitro –Derived Organoids

Culture and Characterization of Chicken Small Intestinal Crypts

Organoid technology for tissue engineering

Human Bile Contains Cholangiocyte Organoid-Initiating Cells Which Expand as Functional Cholangiocytes in Non-canonical Wnt Stimulating Conditions

Generation of hepatobiliary organoids from human induced pluripotent stem cells.

Generation of Organoids from Mouse Extrahepatic Bile Ducts

Human branching cholangiocyte organoids recapitulate functional bile duct formation

Establishment of Patient-Derived Organoid Model from Hydrothorax and Ascites